Expected Symptoms After Tdap Vaccination
Most symptoms after Tdap vaccination are mild, self-limited, and resolve within 24-48 hours; seek urgent medical care if you develop severe allergic symptoms (difficulty breathing, facial swelling, widespread rash), persistent high fever beyond 24 hours, severe headache with neck stiffness, or altered mental status.
Common Expected Reactions (Do Not Require Urgent Care)
The FDA-approved prescribing information for Tdap vaccines identifies these frequent reactions occurring in ≥15% of recipients 1:
Local reactions at injection site:
- Pain (most common, occurring in >20% of recipients)
- Redness and swelling
- Increased arm circumference
- Tenderness
Systemic symptoms:
- Headache
- Fatigue
- Gastrointestinal symptoms (nausea, vomiting, diarrhea)
- Low-grade fever
These reactions typically begin within hours of vaccination and resolve within 1-3 days without treatment 1. You can manage these symptoms with acetaminophen or ibuprofen for pain and fever.
When to Seek Urgent Medical Care
Seek immediate medical attention if you develop:
Severe allergic reaction (anaphylaxis) - within minutes to hours:
- Difficulty breathing or wheezing
- Facial, lip, or throat swelling
- Widespread hives or rash
- Rapid heartbeat or dizziness
- This is a contraindication to future Tdap doses 1
High fever (≥40.5°C or ≥105°F) that:
- Begins more than 24 hours after vaccination
- Persists beyond 24 hours
- These patterns suggest another illness requiring evaluation 2
Neurological symptoms:
- Severe, persistent headache with neck stiffness
- Confusion or altered mental status
- Seizures
- Weakness or numbness in limbs
Extensive limb swelling:
- While swelling of the entire vaccinated limb can occur (reported in ~2% after booster doses), it should be evaluated if accompanied by severe pain, warmth suggesting infection, or systemic symptoms 3
Important Clinical Context
Timing matters for symptom attribution: Fever or other symptoms beginning >24 hours post-vaccination or persisting >24 hours should not be automatically attributed to the vaccine and require evaluation for other causes such as infections 2. This is a common pitfall—don't delay seeking care for potentially serious conditions by assuming all symptoms are vaccine-related.
Safety profile: Large-scale studies demonstrate Tdap has an excellent safety profile. A study of 119,573 elderly recipients found risks comparable to tetanus-diphtheria vaccine alone, with only a small increased rate of inflammatory/allergic events in the first 1-6 days 4. Among pregnant women, no increased risks of serious maternal or fetal outcomes were observed 5.
Rare but serious reactions to be aware of:
- Guillain-Barré syndrome (if you developed this within 6 weeks of a prior tetanus-containing vaccine, discuss with your physician before future doses) 1
- Arthus-type hypersensitivity (severe local reaction; if this occurred previously, wait at least 10 years before another tetanus-containing vaccine) 1
Bottom Line
Feeling poorly after Tdap is common and expected. Pain at the injection site, fatigue, headache, and mild fever are normal immune responses. These symptoms are self-limited and manageable with over-the-counter medications. However, do not dismiss severe symptoms—particularly allergic reactions, high persistent fever, or neurological changes—as "just the vaccine." These warrant immediate medical evaluation.